JNJ | Johnson & Johnson

Are Biotech Stocks a Good Idea Right Now?
Take a look at a few trending biotech stocks and decide if this is something you want to invest in.
By Staff | 6 months ago

New York judge orders Johnson & Johnson to pay $120 million in damages to Brooklyn resident
Olson claimed that she got cancer because of asbestos exposure from Johnson & Johnson baby powder.
By Staff | 8 months ago

Johnson & Johnson to acquire Momenta Pharmaceuticals for $6.5 billion
Johnson & Johnson to enroll 60,000 participants in the late-stage trial for its COVID-19 vaccine.
By Khan | 11 months ago